{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T18:57:15Z","timestamp":1772737035320,"version":"3.50.1"},"reference-count":132,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1045157, 1040830"],"award-info":[{"award-number":["1045157, 1040830"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"DOI":"10.3389\/fped.2017.00058","type":"journal-article","created":{"date-parts":[[2017,3,24]],"date-time":"2017-03-24T03:38:39Z","timestamp":1490326719000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["The Likelihood of Preventing Respiratory Exacerbations in Children and Adolescents with either Chronic Suppurative Lung Disease or Bronchiectasis"],"prefix":"10.3389","volume":"5","author":[{"given":"Kerry-Ann F","family":"O\u2019Grady","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith","family":"Grimwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2017,3,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/ppul.22792","article-title":"Wet cough in children: infective and inflammatory characteristics in broncho-alveolar lavage fluid","volume":"49","author":"Wurzel","year":"2013","journal-title":"Pediatr Pulmonol"},{"issue":"2","key":"B2","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1378\/chest.07-2236","article-title":"What is the burden of chronic cough for families?","volume":"134","author":"Marchant","year":"2008","journal-title":"Chest"},{"issue":"8","key":"B3","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1136\/thoraxjnl-2015-207473","article-title":"A child chronic cough-specific quality of life measure: development and validation","volume":"71","author":"Newcombe","year":"2016","journal-title":"Thorax"},{"issue":"5","key":"B4","doi-asserted-by":"publisher","first-page":"e1576","DOI":"10.1542\/peds.2012-3318","article-title":"A cough algorithm for chronic cough in children: a multicenter, randomized controlled study","volume":"131","author":"Chang","year":"2013","journal-title":"Pediatrics"},{"issue":"8","key":"B5","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1007\/s00431-016-2743-5","article-title":"Paediatric chronic suppurative lung disease: clinical characteristics and outcomes","volume":"175","author":"Goyal","year":"2016","journal-title":"Eur J Pediatr"},{"issue":"6","key":"B6","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1002\/ppul.20821","article-title":"Chronic wet cough: protracted bronchitis, chronic suppurative lung disease and bronchiectasis","volume":"43","author":"Chang","year":"2008","journal-title":"Pediatr Pulmonol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"13731","DOI":"10.1038\/srep13731","article-title":"Clinical characteristics of protracted bacterial bronchitis in Chinese infants","volume":"5","author":"Wang","year":"2015","journal-title":"Sci Rep"},{"issue":"7","key":"B8","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1128\/JCM.00566-12","article-title":"Culture and PCR detection of Haemophilus influenzae and Haemophilus haemolyticus in Australian indigenous children with bronchiectasis","volume":"50","author":"Hare","year":"2012","journal-title":"J Clin Microbiol"},{"issue":"6","key":"B9","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.jpeds.2010.06.002","article-title":"Respiratory bacterial pathogens in the nasopharynx and lower airways of Australian indigenous children with bronchiectasis","volume":"157","author":"Hare","year":"2010","journal-title":"J Pediatr"},{"issue":"9","key":"B10","doi-asserted-by":"publisher","first-page":"e108523","DOI":"10.1371\/journal.pone.0108523","article-title":"Bacterial distribution in the lungs of children with protracted bacterial bronchitis","volume":"9","author":"Narang","year":"2014","journal-title":"PLoS One"},{"key":"B11","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1378\/chest.12-0623","article-title":"Streptococcus pneumoniae and non-typable Haemophilus influenzae causing bacterial bronchitis in children and the impact of vaccination","volume":"143","author":"Priftis","year":"2012","journal-title":"Chest"},{"issue":"2","key":"B12","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.prrv.2010.10.009","article-title":"Airway microbiology and host defences in paediatric non-CF bronchiectasis","volume":"12","author":"Grimwood","year":"2011","journal-title":"Paediatr Respir Rev"},{"issue":"3","key":"B13","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1002\/ppul.21550","article-title":"Lower airway microbiology and cellularity in children with newly diagnosed non-CF bronchiectasis","volume":"47","author":"Kapur","year":"2012","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"B14","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1513\/AnnalsATS.201406-257OC","article-title":"Bronchiectasis in children from Qikiqtani (Baffin) region, Nunavut, Canada","volume":"12","author":"Das","year":"2015","journal-title":"Ann Am Thorac Soc"},{"issue":"7","key":"B15","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1513\/AnnalsATS.201312-456OC","article-title":"Three clinically distinct chronic pediatric airway infections share a common core microbiota","volume":"11","author":"van der Gast","year":"2014","journal-title":"Ann Am Thorac Soc"},{"issue":"3","key":"B16","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/ppul.23351","article-title":"Protracted bacterial bronchitis: the last decade and the road ahead","volume":"51","author":"Chang","year":"2016","journal-title":"Pediatr Pulmonol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00408-015-9815-6","article-title":"Update on pediatric cough","volume":"194","author":"Kantar","year":"2016","journal-title":"Lung"},{"issue":"5","key":"B18","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1002\/ppul.23380","article-title":"Pediatric bronchiectasis: no longer an orphan disease","volume":"51","author":"Goyal","year":"2016","journal-title":"Pediatr Pulmonol"},{"issue":"6","key":"B19","doi-asserted-by":"crossref","first-page":"356","DOI":"10.5694\/j.1326-5377.2010.tb03949.x","article-title":"Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand","volume":"193","author":"Chang","year":"2010","journal-title":"Med J Aust"},{"issue":"5","key":"B20","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.chest.2016.06.030","article-title":"Protracted bacterial bronchitis in children: natural history and risk factors for bronchiectasis","volume":"150","author":"Wurzel","year":"2016","journal-title":"Chest"},{"issue":"1","key":"B21","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ccm.2015.11.005","article-title":"Using cystic fibrosis therapies for non-cystic fibrosis bronchiectasis","volume":"37","author":"ElMaraachli","year":"2016","journal-title":"Clin Chest Med"},{"issue":"5","key":"B22","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1378\/chest.07-0490","article-title":"Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis","volume":"132","author":"Martinez-Garcia","year":"2007","journal-title":"Chest"},{"issue":"4","key":"B23","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1183\/09031936.00003709","article-title":"Mortality in bronchiectasis: a long-term study assessing the factors influencing survival","volume":"34","author":"Loebinger","year":"2009","journal-title":"Eur Respir J"},{"issue":"3","key":"B24","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1136\/thx.2008.100958","article-title":"Non-cystic fibrosis bronchiectasis in childhood: longitudinal growth and lung function","volume":"64","author":"Bastardo","year":"2009","journal-title":"Thorax"},{"issue":"11","key":"B25","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1016\/j.rmed.2009.05.007","article-title":"Exacerbations in noncystic fibrosis bronchiectasis: clinical features and investigations","volume":"103","author":"Kapur","year":"2009","journal-title":"Respir Med"},{"issue":"1","key":"B26","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1378\/chest.09-2932","article-title":"Longitudinal growth and lung function in pediatric non-cystic fibrosis bronchiectasis: what influences lung function stability?","volume":"138","author":"Kapur","year":"2010","journal-title":"Chest"},{"issue":"4","key":"B27","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1378\/chest.10-0099","article-title":"Trends and burden of bronchiectasis-associated hospitalizations in the United States, 1993-2006","volume":"138","author":"Seitz","year":"2010","journal-title":"Chest"},{"issue":"7","key":"B28","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1517\/14656566.5.7.1471","article-title":"Treatment of paediatric non-cystic fibrosis bronchiectasis","volume":"5","author":"Edwards","year":"2004","journal-title":"Expert Opin Pharmacother"},{"issue":"7","key":"B29","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1136\/thoraxjnl-2011-200467","article-title":"Cystic fibrosis, primary ciliary dyskinesia and non-cystic fibrosis bronchiectasis: update 2008-11","volume":"67","author":"Flight","year":"2012","journal-title":"Thorax"},{"key":"B30","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1056\/NEJMcp012477","article-title":"Acute exacerbations of chronic obstructive pulmonary disease","volume":"346","author":"Stoller","year":"2002","journal-title":"N Engl J Med"},{"key":"B31","article-title":"Bronchiectasis","volume-title":"European Lung White Book: Respiratory Health and Disease in Europe","author":"European Respiratory Society","year":"2013"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1183\/13993003.00152-2015","article-title":"The reproducibility and responsiveness of the lung clearance index in bronchiectasis","volume":"46","author":"Grillo","year":"2015","journal-title":"Eur Respir J"},{"key":"B33","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/1471-2431-12-122","article-title":"Azithromycin for Indigenous children with bronchiectasis: study protocol for a multi-centre randomized controlled trial","volume":"12","author":"Valery","year":"2012","journal-title":"BMC Pediatr"},{"key":"B34","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/1745-6215-13-156","article-title":"Antibiotics for bronchiectasis exacerbations in children: rationale and study protocol for a randomised placebo-controlled trial","volume":"13","author":"Chang","year":"2012","journal-title":"Trials"},{"key":"B35","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1745-6215-14-53","article-title":"Bronchiectasis exacerbation study on azithromycin and amoxycillin-clavulanate for respiratory exacerbations in children (BEST-2): study protocol for a randomized controlled trial","volume":"14","author":"Chang","year":"2013","journal-title":"Trials"},{"key":"B36","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/1745-6215-14-282","article-title":"Does a 10-valent pneumococcal-Haemophilus influenzae protein D conjugate vaccine prevent respiratory exacerbations in children with recurrent protracted bacterial bronchitis, chronic suppurative lung disease and bronchiectasis: protocol for a randomised controlled trial","volume":"14","author":"O\u2019Grady","year":"2013","journal-title":"Trials"},{"issue":"1","key":"B37","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/ppul.21518","article-title":"Defining pulmonary exacerbation in children with non-cystic fibrosis bronchiectasis","volume":"47","author":"Kapur","year":"2012","journal-title":"Pediatr Pulmonol"},{"issue":"3","key":"B38","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1136\/thx.2006.060913","article-title":"Exacerbations in cystic fibrosis: 4 \u2013 non-cystic fibrosis bronchiectasis","volume":"63","author":"Chang","year":"2008","journal-title":"Thorax"},{"issue":"6","key":"B39","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1111\/j.1469-0691.2010.03410.x","article-title":"Differences in nasopharyngeal bacterial carriage in preschool children from different socio-economic origins","volume":"17","author":"Jourdain","year":"2011","journal-title":"Clin Microbiol Infect"},{"issue":"8","key":"B40","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1136\/archdischild-2013-305147","article-title":"Respiratory viruses in exacerbations of non-cystic fibrosis bronchiectasis in children","volume":"99","author":"Kapur","year":"2014","journal-title":"Arch Dis Child"},{"issue":"1","key":"B41","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1093\/cid\/ciu225","article-title":"Adenovirus species C is associated with chronic suppurative lung diseases in children","volume":"59","author":"Wurzel","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"3","key":"B42","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1378\/chest.14-0126","article-title":"Respiratory exacerbations in indigenous children from two countries with non-cystic fibrosis chronic suppurative lung disease\/bronchiectasis","volume":"146","author":"Redding","year":"2014","journal-title":"Chest"},{"issue":"3","key":"B43","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1159\/000085362","article-title":"Non-cystic-fibrosis bronchiectasis in children: a persisting problem in developing countries","volume":"72","author":"Karadag","year":"2005","journal-title":"Respiration"},{"issue":"7","key":"B44","doi-asserted-by":"crossref","first-page":"386","DOI":"10.5694\/j.1326-5377.2008.tb02085.x","article-title":"Management of bronchiectasis and chronic suppurative lung disease in indigenous children and adults from rural and remote Australian communities","volume":"189","author":"Chang","year":"2008","journal-title":"Med J Aust"},{"issue":"7","key":"B45","doi-asserted-by":"publisher","first-page":"CD010337","DOI":"10.1002\/14651858.CD010337.pub2","article-title":"Interventions for bronchiectasis: an overview of Cochrane systematic reviews","author":"Welsh","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"B46","doi-asserted-by":"publisher","first-page":"CD011530","DOI":"10.1002\/14651858.CD011530.pub2","article-title":"Antibiotics for preventing lower respiratory tract infections in high-risk children aged 12 years and under","author":"Onakpoya","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"B47","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1136\/thx.2009.126128","article-title":"Controlled trial of cycled antibiotic prophylaxis to prevent initial Pseudomonas aeruginosa infection in children with cystic fibrosis","volume":"65","author":"Tramper-Stranders","year":"2010","journal-title":"Thorax"},{"issue":"10","key":"B48","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1136\/thx.2005.057950","article-title":"Long term effects of azithromycin in patients with cystic fibrosis: a double blind, placebo controlled trial","volume":"61","author":"Clement","year":"2006","journal-title":"Thorax"},{"issue":"17","key":"B49","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1001\/jama.2010.563","article-title":"Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial","volume":"303","author":"Saiman","year":"2010","journal-title":"JAMA"},{"issue":"5","key":"B50","first-page":"416","article-title":"Long-term clarithromycin in cystic fibrosis: effects on inflammatory markers in BAL and clinical status","volume":"51","author":"Dogru","year":"2009","journal-title":"Turk J Pediatr"},{"issue":"9338","key":"B51","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/S0140-6736(02)11081-6","article-title":"Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial","volume":"360","author":"Equi","year":"2002","journal-title":"Lancet"},{"issue":"4","key":"B52","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/ppul.20097","article-title":"Treatment with tobramycin solution for inhalation reduces hospitalizations in young CF subjects with mild lung disease","volume":"38","author":"Murphy","year":"2004","journal-title":"Pediatr Pulmonol"},{"issue":"3","key":"B53","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1067\/mpd.2002.121930","article-title":"Antibiotic prophylaxis in infants and young children with cystic fibrosis: a randomized controlled trial","volume":"140","author":"Stutman","year":"2002","journal-title":"J Pediatr"},{"issue":"8","key":"B54","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/S2213-2600(13)70185-1","article-title":"Long-term azithromycin for indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bronchiectasis Intervention Study): a multicentre, double-blind, randomised controlled trial","volume":"1","author":"Valery","year":"2013","journal-title":"Lancet Respir Med"},{"issue":"11","key":"B55","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1007\/s10096-015-2480-0","article-title":"Nasopharyngeal carriage and macrolide resistance in indigenous children with bronchiectasis randomized to long-term azithromycin or placebo","volume":"34","author":"Hare","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"8","key":"B56","doi-asserted-by":"publisher","first-page":"e70478","DOI":"10.1371\/journal.pone.0070478","article-title":"Longitudinal nasopharyngeal carriage and antibiotic resistance of respiratory bacteria in indigenous Australian and Alaska native children with bronchiectasis","volume":"8","author":"Hare","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"B57","doi-asserted-by":"publisher","first-page":"CD001392","DOI":"10.1002\/14651858.CD001392.pub3","article-title":"Prolonged antibiotics for non-cystic fibrosis bronchiectasis in children and adults","author":"Hnin","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"B58","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1365-2710.2006.00708.x","article-title":"Effects of claritromycin on inflammatory parameters and clinical conditions in children with bronchiectasis","volume":"31","author":"Yalcin","year":"2006","journal-title":"J Clin Pharm Ther"},{"issue":"5","key":"B59","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1183\/09031936.97.10050994","article-title":"Effect of roxithromycin on airway responsiveness in children with bronchiectasis: a double-blind, placebo-controlled study","volume":"10","author":"Koh","year":"1997","journal-title":"Eur Respir J"},{"issue":"6","key":"B60","doi-asserted-by":"publisher","first-page":"CD008695","DOI":"10.1002\/14651858.CD008695.pub2","article-title":"Short courses of antibiotics for children and adults with bronchiectasis","author":"Wurzel","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"B61","first-page":"859","article-title":"Mucolytics, expectorants, and mucokinetic medications","volume":"52","author":"Rubin","year":"2007","journal-title":"Respir Care"},{"issue":"2","key":"B62","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.ccm.2012.02.008","article-title":"Pharmacologic agents for mucus clearance in bronchiectasis","volume":"33","author":"Nair","year":"2012","journal-title":"Clin Chest Med"},{"issue":"11","key":"B63","doi-asserted-by":"publisher","first-page":"CD001831","DOI":"10.1002\/14651858.CD001831.pub5","article-title":"Over-the-counter (OTC) medications for acute cough in children and adults in community settings","author":"Smith","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"B64","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1542\/peds.2013-2236","article-title":"Cough and cold medication adverse events after market withdrawal and labeling revision","volume":"132","author":"Hampton","year":"2013","journal-title":"Pediatrics"},{"issue":"1","key":"B65","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1089\/jam.2006.19.100","article-title":"Hyperosmolar agents and clearance of mucus in the diseased airway","volume":"19","author":"Daviskas","year":"2006","journal-title":"J Aerosol Med"},{"issue":"5","key":"B66","doi-asserted-by":"publisher","first-page":"CD001289","DOI":"10.1002\/14651858.CD001289.pub2","article-title":"Mucolytics for bronchiectasis","author":"Wilkinson","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"B67","doi-asserted-by":"publisher","first-page":"611","DOI":"10.2147\/BTT.S3052","article-title":"Review of recombinant human deoxyribonuclease (rhDNase) in the management of patients with cystic fibrosis","volume":"2","author":"Pressler","year":"2008","journal-title":"Biologics"},{"issue":"5","key":"B68","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1378\/chest.113.5.1329","article-title":"Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. rhDNase Study Group","volume":"113","author":"O\u2019Donnell","year":"1998","journal-title":"Chest"},{"issue":"7","key":"B69","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.4187\/respcare.04165","article-title":"AARC clinical practice guideline: effectiveness of pharmacologic airway clearance therapies in hospitalized patients","volume":"60","author":"Strickland","year":"2015","journal-title":"Respir Care"},{"issue":"1","key":"B70","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4103\/1817-1737.25870","article-title":"Pathogenesis, etiology and treatment of bronchiectasis","volume":"1","author":"AL-Shirawi","year":"2006","journal-title":"Ann Thorac Med"},{"issue":"7","key":"B71","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1136\/thx.2010.142778","article-title":"British Thoracic Society guideline for non-CF bronchiectasis","volume":"65","author":"Pasteur","year":"2010","journal-title":"Thorax"},{"issue":"10","key":"B72","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1164\/rccm.201505-0926UP","article-title":"Update in bronchiectasis 2014","volume":"192","author":"Amalakuhan","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"B73","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1136\/thx.39.3.179","article-title":"Atopy, immunological changes, and respiratory function in bronchiectasis","volume":"39","author":"Murphy","year":"1984","journal-title":"Thorax"},{"issue":"3","key":"B74","doi-asserted-by":"publisher","first-page":"130","DOI":"10.5694\/mjac14.00287","article-title":"Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand Thoracic Society of Australia and New Zealand guidelines","volume":"202","author":"Chang","year":"2015","journal-title":"Med J Aust"},{"issue":"1","key":"B75","doi-asserted-by":"publisher","first-page":"CD000996","DOI":"10.1002\/14651858.CD000996.pub2","article-title":"Inhaled steroids for bronchiectasis","author":"Kapur","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"B76","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1183\/09031936.97.10122784","article-title":"Bronchiectasis: an orphan disease with a poorly-understood prognosis","volume":"10","author":"Keistinen","year":"1997","journal-title":"Eur Respir J"},{"issue":"11","key":"B77","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1111\/j.1398-9995.1997.tb00186.x","article-title":"Links between hospital diagnoses of bronchiectasis and asthma","volume":"52","author":"Saynajakangas","year":"1997","journal-title":"Allergy"},{"issue":"237","key":"B78","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1136\/adc.44.237.551","article-title":"Bronchiectasis. Third report on a follow-up study of medical and surgical cases from childhood","volume":"44","author":"Field","year":"1969","journal-title":"Arch Dis Child"},{"key":"B79","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s40413-016-0117-0","article-title":"The use of inhaled corticosteroids in pediatric asthma: update","volume":"9","author":"Hossny","year":"2016","journal-title":"World Allergy Organ J"},{"issue":"10","key":"B80","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1111\/jpc.13356","article-title":"Persistent growth effects of inhaled corticosteroids","volume":"52","author":"Ohn","year":"2016","journal-title":"J Paediatr Child Health"},{"key":"B81","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/1471-2466-14-107","article-title":"Treatment adherence and health outcomes in patients with bronchiectasis","volume":"14","author":"McCullough","year":"2014","journal-title":"BMC Pulm Med"},{"issue":"6","key":"B82","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1111\/hex.12217","article-title":"\u2018All illness is personal to that individual\u2019: a qualitative study of patients\u2019 perspectives on treatment adherence in bronchiectasis","volume":"18","author":"McCullough","year":"2015","journal-title":"Health Expect"},{"issue":"6","key":"B83","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/j.1365-2710.2008.00951.x","article-title":"Withdrawal of inhaled steroids in children with non-cystic fibrosis bronchiectasis","volume":"33","author":"Guran","year":"2008","journal-title":"J Clin Pharm Ther"},{"issue":"7629","key":"B84","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1136\/bmj.39384.657118.80","article-title":"Treatment of bronchiectasis in adults","volume":"335","author":"ten Hacken","year":"2007","journal-title":"BMJ"},{"issue":"4","key":"B85","doi-asserted-by":"publisher","first-page":"CD002162","DOI":"10.1002\/14651858.CD002162","article-title":"Oral steroids for bronchiectasis (stable and acute exacerbations)","author":"Lasserson","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"B86","doi-asserted-by":"publisher","first-page":"CD007525","DOI":"10.1002\/14651858.CD007525.pub3","article-title":"Inhaled non-steroid anti-inflammatories for children and adults with bronchiectasis","author":"Pizzutto","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"B87","doi-asserted-by":"publisher","first-page":"CD006427","DOI":"10.1002\/14651858.CD006427.pub2","article-title":"Oral non steroid anti-inflammatories for children and adults with bronchiectasis","author":"Kapur","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"B88","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1586\/17476348.2014.852960","article-title":"Vaccines for children and adults with chronic lung disease: efficacy against acute exacerbations","volume":"8","author":"O\u2019Grady","year":"2014","journal-title":"Expert Rev Respir Med"},{"issue":"4","key":"B89","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1164\/rccm.2211009","article-title":"Immunity to nontypeable Haemophilus influenzae: elucidating protective responses","volume":"167","author":"Murphy","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"B90","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1128\/CVI.00089-15","article-title":"Vaccines for nontypeable Haemophilus influenzae: the future is now","volume":"22","author":"Murphy","year":"2015","journal-title":"Clin Vaccine Immunol"},{"issue":"2","key":"B91","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.vaccine.2014.11.024","article-title":"Improving immunity to Haemophilus influenzae in children with chronic suppurative lung disease","volume":"33","author":"Pizzutto","year":"2015","journal-title":"Vaccine"},{"issue":"6","key":"B92","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.vaccine.2014.12.013","article-title":"Interventions to increase influenza vaccination rates in children with high-risk conditions \u2013 a systematic review","volume":"33","author":"Aigbogun","year":"2015","journal-title":"Vaccine"},{"issue":"5","key":"B93","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1093\/cid\/ciu348","article-title":"Risk of pneumococcal disease in children with chronic medical conditions in the era of pneumococcal conjugate vaccine","volume":"59","author":"Pelton","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"3","key":"B94","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.vaccine.2006.09.045","article-title":"Increased risk of chronic suppurative lung disease after measles or pertussis in non-vaccinated children","volume":"25","author":"Montella","year":"2007","journal-title":"Vaccine"},{"issue":"2","key":"B95","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1055\/s-0035-1546820","article-title":"Airway clearance strategies in cystic fibrosis and non-cystic fibrosis bronchiectasis","volume":"36","author":"Main","year":"2015","journal-title":"Semin Respir Crit Care Med"},{"issue":"2","key":"B96","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1177\/0394632015584724","article-title":"Mucociliary clearance techniques for treating non-cystic fibrosis bronchiectasis: is there evidence?","volume":"28","author":"Snijders","year":"2015","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"11","key":"B97","doi-asserted-by":"publisher","first-page":"CD008351","DOI":"10.1002\/14651858.CD008351.pub3","article-title":"Airway clearance techniques for bronchiectasis","author":"Lee","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"B98","first-page":"105","article-title":"Objective and subjective results of a comparative study in children with chronic lung diseases [Physiotherapie mit dem VRP1-Gerat: Objektive und subjektive Ergebnisse einer vergleichenden Studie bei Kindern mit chronischen Lungenerkrankungen]","volume":"9","author":"Kurz","year":"1997","journal-title":"Prev Rehabil"},{"issue":"1","key":"B99","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1378\/chest.15-2065","article-title":"Children with chronic wet or productive cough \u2013 treatment and investigations; a systematic review","volume":"149","author":"Chang","year":"2016","journal-title":"Chest"},{"issue":"1","key":"B100","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12875-016-0535-7","article-title":"Developing interprofessional care plans in chronic care: a scoping review","volume":"17","author":"van Dongen","year":"2016","journal-title":"BMC Fam Pract"},{"key":"B101","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12875-016-0456-5","article-title":"Interprofessional collaboration regarding patients\u2019 care plans in primary care: a focus group study into influential factors","volume":"17","author":"van Dongen","year":"2016","journal-title":"BMC Fam Pract"},{"issue":"3","key":"B102","doi-asserted-by":"publisher","first-page":"CD010523","DOI":"10.1002\/14651858.CD010523.pub2","article-title":"Personalised care planning for adults with chronic or long-term health conditions","author":"Coulter","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"B103","doi-asserted-by":"publisher","first-page":"CD005074","DOI":"10.1002\/14651858.CD005074.pub3","article-title":"Action plans with limited patient education only for exacerbations of chronic obstructive pulmonary disease","author":"Walters","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"B104","doi-asserted-by":"publisher","first-page":"CD004910","DOI":"10.1002\/14651858.CD004910.pub2","article-title":"Effectiveness of shared care across the interface between primary and specialty care in chronic disease management","author":"Smith","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"B105","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.prrv.2016.09.003","article-title":"Interventions to prevent respiratory diseases \u2013 nutrition and the developing world","volume":"22","author":"Karim","year":"2017","journal-title":"Paediatr Respir Rev"},{"issue":"3\u2009Suppl\u20091","key":"B106","first-page":"12","article-title":"The immunobiological and clinical role of vitamin D in obstructive lung diseases","volume":"107","author":"Solidoro","year":"2016","journal-title":"Minerva Med"},{"key":"B107","doi-asserted-by":"publisher","first-page":"R1909","DOI":"10.1002\/rmv.1909","article-title":"Vitamin D modulation of innate immune responses to respiratory viral infections","volume":"27","author":"Zdrenghea","year":"2016","journal-title":"Rev Med Virol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.2147\/COPD.S89763","article-title":"Vitamin D deficiency is associated with the severity of COPD: a systematic review and meta-analysis","volume":"10","author":"Zhu","year":"2015","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"7","key":"B109","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1017\/S000711451500207X","article-title":"Vitamin D supplementation for the prevention of childhood acute respiratory infections: a systematic review of randomised controlled trials","volume":"114","author":"Xiao","year":"2015","journal-title":"Br J Nutr"},{"issue":"11","key":"B110","doi-asserted-by":"publisher","first-page":"e234","DOI":"10.1038\/nutd.2016.46","article-title":"The link between soda intake and asthma: science points to the high-fructose corn syrup, not the preservatives: a commentary","volume":"6","author":"DeChristopher","year":"2016","journal-title":"Nutr Diabetes"},{"key":"B111","doi-asserted-by":"publisher","first-page":"e199","DOI":"10.1038\/nutd.2016.7","article-title":"Intake of high-fructose corn syrup sweetened soft drinks, fruit drinks and apple juice is associated with prevalent arthritis in US adults, aged 20-30 years","volume":"6","author":"DeChristopher","year":"2016","journal-title":"Nutr Diabetes"},{"key":"B112","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12937-015-0097-x","article-title":"Intake of high fructose corn syrup sweetened soft drinks is associated with prevalent chronic bronchitis in U.S. Adults, ages 20-55 y","volume":"14","author":"DeChristopher","year":"2015","journal-title":"Nutr J"},{"key":"B113","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/5584_2015_192","article-title":"Growth, nutritional status, and pulmonary function in children with chronic recurrent bronchitis","volume":"885","author":"Umlawska","year":"2016","journal-title":"Adv Exp Med Biol"},{"issue":"7238","key":"B114","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1136\/bmj.320.7238.827","article-title":"Immediate and long term effects of weight reduction in obese people with asthma: randomised controlled study","volume":"320","author":"Stenius-Aarniala","year":"2000","journal-title":"BMJ"},{"issue":"2","key":"B115","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S2213-8587(15)00419-2","article-title":"Sweetening of the global diet, particularly beverages: patterns, trends, and policy responses","volume":"4","author":"Popkin","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"B116","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/(SICI)1099-0496(199901)27:15::AID-PPUL33.0.CO;2-5","article-title":"Meta-analysis on the association between environmental tobacco smoke (ETS) exposure and the prevalence of lower respiratory tract infection in early childhood","volume":"27","author":"Li","year":"1999","journal-title":"Pediatr Pulmonol"},{"issue":"8","key":"B117","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1093\/ntr\/ntu046","article-title":"Smokers still underestimate the risks posed by secondhand smoke: a repeated cross-sectional study","volume":"16","author":"Lonergan","year":"2014","journal-title":"Nicotine Tob Res"},{"issue":"5","key":"B118","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1093\/ntr\/ntt180","article-title":"Children with asthma versus healthy children: differences in secondhand smoke exposure and caregiver perceived risk","volume":"16","author":"Borrelli","year":"2014","journal-title":"Nicotine Tob Res"},{"issue":"2","key":"B119","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1037\/hea0000220","article-title":"Comparison of secondhand smoke exposure in minority and nonminority children with asthma","volume":"35","author":"Fedele","year":"2016","journal-title":"Health Psychol"},{"issue":"12","key":"B120","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1164\/rccm.201404-0618OC","article-title":"Effectiveness of motivational interviewing to reduce head start children\u2019s secondhand smoke exposure. a randomized clinical trial","volume":"189","author":"Eakin","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"B121","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s10995-016-2099-5","article-title":"A cluster randomised controlled trial of a brief child health nurse intervention to reduce infant secondhand smoke exposure","volume":"21","author":"Daly","year":"2017","journal-title":"Matern Child Health J"},{"issue":"1","key":"B122","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1093\/ntr\/ntu128","article-title":"Effect of a family-centered, secondhand smoke intervention to reduce respiratory illness in indigenous infants in Australia and New Zealand: a randomized controlled trial","volume":"17","author":"Walker","year":"2015","journal-title":"Nicotine Tob Res"},{"issue":"4","key":"B123","doi-asserted-by":"publisher","first-page":"CD001746","DOI":"10.1002\/14651858.CD001746.pub2","article-title":"Family and carer smoking control programmes for reducing children\u2019s exposure to environmental tobacco smoke","author":"Priest","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"4S","key":"B124","doi-asserted-by":"publisher","first-page":"S61","DOI":"10.1016\/j.jadohealth.2016.06.021","article-title":"Interventions for adolescent substance abuse: an overview of systematic reviews","volume":"59","author":"Das","year":"2016","journal-title":"J Adolesc Health"},{"key":"B125","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1097\/ADM.0000000000000272","article-title":"Frequency of E-cigarette use, health status, and risk and protective health behaviors in adolescents","volume":"11","author":"Dunbar","year":"2017","journal-title":"J Addict Med"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201604-0804OC","article-title":"Electronic-cigarette use and respiratory symptoms in adolescents","author":"McConnell","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"B127","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1159\/000375170","article-title":"Rehabilitation in patients with chronic respiratory disease other than chronic obstructive pulmonary disease: exercise and physical activity interventions in cystic fibrosis and non-cystic fibrosis bronchiectasis","volume":"89","author":"Burtin","year":"2015","journal-title":"Respiration"},{"issue":"12","key":"B128","doi-asserted-by":"publisher","first-page":"e316","DOI":"10.3928\/00904481-20141124-11","article-title":"Can I play?","volume":"43","author":"LeBlanc","year":"2014","journal-title":"Pediatr Ann"},{"issue":"5 Suppl 1","key":"B129","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1249\/01.mss.0000487732.62636.11","article-title":"Combinations of physical activity, sedentary behaviour and sleep: relationships with health in children and youth","volume":"48","author":"Saunders","year":"2016","journal-title":"Med Sci Sports Exerc"},{"key":"B130","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.amepre.2016.10.009","article-title":"The longitudinal impact of NFL PLAY 60 programming on youth aerobic capacity and BMI","volume":"52","author":"Bai","year":"2017","journal-title":"Am J Prev Med"},{"key":"B131","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1465-9921-15-44","article-title":"The short and long term effects of exercise training in non-cystic fibrosis bronchiectasis \u2013 a randomised controlled trial","volume":"15","author":"Lee","year":"2014","journal-title":"Respir Res"},{"issue":"10","key":"B132","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1586\/14787210.2014.952282","article-title":"Antimicrobial treatment of non-cystic fibrosis bronchiectasis","volume":"12","author":"Grimwood","year":"2014","journal-title":"Expert Rev Anti Infect Ther"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fped.2017.00058\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,4]],"date-time":"2020-10-04T09:05:32Z","timestamp":1601802332000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fped.2017.00058\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,24]]},"references-count":132,"URL":"https:\/\/doi.org\/10.3389\/fped.2017.00058","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,24]]}}}